# FDA Inspection 1277120 - Mark J. Hamblin, MD - July 18, 2025

Source: https://www.keypedia.com/records/fda_inspections/mark-j-hamblin-md/c4b5c991-3cd8-4915-93bd-1a36f121c7c4
Source feed: FDA_Inspections

> FDA Inspection 1277120 for Mark J. Hamblin, MD on July 18, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1277120
- Company Name: Mark J. Hamblin, MD
- Inspection Date: 2025-07-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1277120 - 2025-07-18](https://www.keypedia.com/records/fda_inspections/mark-j-hamblin-md/1a106fd2-3ec8-4fd5-b1db-aa41ce8a5d5c)

Company: https://www.keypedia.com/companies/mark-j-hamblin-md/6201b6f1-585e-4a4c-b594-d7f696617cb0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c